The Society for Immunotherapy of Cancer (SITC) hosted Session 208b during the 39th Annual Meeting & Pre-Conference Programs on Saturday, November 9, 2024. Available here are the presentation slides and video from “Session 208b: Cellular Therapies - Financial Toxicities, Access to Care” as permitted by presenters.
Nirav Shah, MD, MSHP – Medical College of Wisconsin
Anna Sureda, MD, PhD – Barcelona Hematology Institute
This session will explore various aspects of CAR-T and their impact on patients. First we will evaluate the financial toxicities to the patients and its potential harms with cellular therapies. Next we will discuss alternative models of cell therapy manufacturing and how it may increase accessibility to these products to different populations and its global implications. Lastly, we will review the role of disparities and how they impact access to care.
To view the entire program schedule (including presenter permission to post) please click here.
01:27:14